| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |